nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.294	0.542	CbGaD
Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.248	0.458	CbGaD
Fluphenazine—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0593	0.269	CbGbCtD
Fluphenazine—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0343	0.156	CbGbCtD
Fluphenazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0332	0.151	CbGbCtD
Fluphenazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0332	0.151	CbGbCtD
Fluphenazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0296	0.135	CbGbCtD
Fluphenazine—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0157	0.0712	CbGbCtD
Fluphenazine—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0148	0.0673	CbGbCtD
Fluphenazine—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00954	0.256	CbGeAlD
Fluphenazine—Brain injury—Aminophylline—chronic obstructive pulmonary disease	0.00951	0.092	CcSEcCtD
Fluphenazine—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00346	0.0931	CbGeAlD
Fluphenazine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.00301	0.0291	CcSEcCtD
Fluphenazine—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.00281	0.0272	CcSEcCtD
Fluphenazine—Pigmentation skin—Prednisone—chronic obstructive pulmonary disease	0.00226	0.0219	CcSEcCtD
Fluphenazine—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.0196	CcSEcCtD
Fluphenazine—Appetite absent—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.0193	CcSEcCtD
Fluphenazine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00185	0.0179	CcSEcCtD
Fluphenazine—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.0167	CcSEcCtD
Fluphenazine—Renal failure acute—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.0157	CcSEcCtD
Fluphenazine—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.0135	CcSEcCtD
Fluphenazine—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.0014	0.0135	CcSEcCtD
Fluphenazine—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00139	0.0134	CcSEcCtD
Fluphenazine—Pigmentation disorder—Prednisone—chronic obstructive pulmonary disease	0.00124	0.012	CcSEcCtD
Fluphenazine—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.00122	0.0118	CcSEcCtD
Fluphenazine—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0113	CcSEcCtD
Fluphenazine—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00114	0.011	CcSEcCtD
Fluphenazine—Leukocytosis—Formoterol—chronic obstructive pulmonary disease	0.00112	0.0108	CcSEcCtD
Fluphenazine—Leukocytosis—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.0108	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.0103	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.01	CcSEcCtD
Fluphenazine—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00995	CcSEcCtD
Fluphenazine—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00994	CcSEcCtD
Fluphenazine—CALM3—bronchus—chronic obstructive pulmonary disease	0.00101	0.0271	CbGeAlD
Fluphenazine—CALM3—smooth muscle tissue—chronic obstructive pulmonary disease	0.000985	0.0265	CbGeAlD
Fluphenazine—CALM2—respiratory system—chronic obstructive pulmonary disease	0.00096	0.0258	CbGeAlD
Fluphenazine—CALM1—respiratory system—chronic obstructive pulmonary disease	0.000956	0.0257	CbGeAlD
Fluphenazine—CALM3—trachea—chronic obstructive pulmonary disease	0.000904	0.0243	CbGeAlD
Fluphenazine—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000883	0.0237	CbGeAlD
Fluphenazine—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00087	0.00841	CcSEcCtD
Fluphenazine—CALM2—connective tissue—chronic obstructive pulmonary disease	0.000845	0.0227	CbGeAlD
Fluphenazine—CALM1—connective tissue—chronic obstructive pulmonary disease	0.000841	0.0226	CbGeAlD
Fluphenazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.000837	0.0081	CcSEcCtD
Fluphenazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.000837	0.0081	CcSEcCtD
Fluphenazine—Eczema—Montelukast—chronic obstructive pulmonary disease	0.000831	0.00804	CcSEcCtD
Fluphenazine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.000827	0.008	CcSEcCtD
Fluphenazine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.000817	0.0079	CcSEcCtD
Fluphenazine—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.000801	0.00775	CcSEcCtD
Fluphenazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00079	0.00764	CcSEcCtD
Fluphenazine—CALM2—bronchus—chronic obstructive pulmonary disease	0.00079	0.0213	CbGeAlD
Fluphenazine—CALM1—bronchus—chronic obstructive pulmonary disease	0.000787	0.0212	CbGeAlD
Fluphenazine—CALM2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000773	0.0208	CbGeAlD
Fluphenazine—CALM1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00077	0.0207	CbGeAlD
Fluphenazine—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.000769	0.00743	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000759	0.00734	CcSEcCtD
Fluphenazine—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.000756	0.00731	CcSEcCtD
Fluphenazine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000747	0.00722	CcSEcCtD
Fluphenazine—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000745	0.02	CbGeAlD
Fluphenazine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000717	0.00694	CcSEcCtD
Fluphenazine—CALM2—trachea—chronic obstructive pulmonary disease	0.00071	0.0191	CbGeAlD
Fluphenazine—CALM1—trachea—chronic obstructive pulmonary disease	0.000706	0.019	CbGeAlD
Fluphenazine—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000697	0.0188	CbGeAlD
Fluphenazine—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.00067	0.018	CbGeAlD
Fluphenazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.000659	0.00637	CcSEcCtD
Fluphenazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.000659	0.00637	CcSEcCtD
Fluphenazine—CALM3—lung—chronic obstructive pulmonary disease	0.000649	0.0175	CbGeAlD
Fluphenazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.000646	0.00624	CcSEcCtD
Fluphenazine—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00623	CcSEcCtD
Fluphenazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000642	0.00621	CcSEcCtD
Fluphenazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.000639	0.00618	CcSEcCtD
Fluphenazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000631	0.00611	CcSEcCtD
Fluphenazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00602	CcSEcCtD
Fluphenazine—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000614	0.0165	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000613	0.00592	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000613	0.00592	CcSEcCtD
Fluphenazine—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000603	0.0162	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.0006	0.0058	CcSEcCtD
Fluphenazine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000587	0.00567	CcSEcCtD
Fluphenazine—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000582	0.0157	CbGeAlD
Fluphenazine—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.000579	0.0056	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00559	CcSEcCtD
Fluphenazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000576	0.00557	CcSEcCtD
Fluphenazine—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000564	0.0152	CbGeAlD
Fluphenazine—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000561	0.0151	CbGeAlD
Fluphenazine—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.000559	0.0054	CcSEcCtD
Fluphenazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00537	CcSEcCtD
Fluphenazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000555	0.00536	CcSEcCtD
Fluphenazine—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.000549	0.00531	CcSEcCtD
Fluphenazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000544	0.00526	CcSEcCtD
Fluphenazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000536	0.00519	CcSEcCtD
Fluphenazine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00052	0.00503	CcSEcCtD
Fluphenazine—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00503	CcSEcCtD
Fluphenazine—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00503	CcSEcCtD
Fluphenazine—HRH1—trachea—chronic obstructive pulmonary disease	0.000515	0.0139	CbGeAlD
Fluphenazine—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000513	0.0138	CbGeAlD
Fluphenazine—CALM2—lung—chronic obstructive pulmonary disease	0.00051	0.0137	CbGeAlD
Fluphenazine—CALM1—lung—chronic obstructive pulmonary disease	0.000508	0.0137	CbGeAlD
Fluphenazine—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000506	0.0136	CbGeAlD
Fluphenazine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00476	CcSEcCtD
Fluphenazine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000491	0.00475	CcSEcCtD
Fluphenazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000481	0.00465	CcSEcCtD
Fluphenazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000474	0.00458	CcSEcCtD
Fluphenazine—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000469	0.0126	CbGeAlD
Fluphenazine—DRD2—lung—chronic obstructive pulmonary disease	0.000469	0.0126	CbGeAlD
Fluphenazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000463	0.00447	CcSEcCtD
Fluphenazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00046	0.00445	CcSEcCtD
Fluphenazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000453	0.00438	CcSEcCtD
Fluphenazine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000451	0.00436	CcSEcCtD
Fluphenazine—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00427	CcSEcCtD
Fluphenazine—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00427	CcSEcCtD
Fluphenazine—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.00044	0.00425	CcSEcCtD
Fluphenazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000439	0.00424	CcSEcCtD
Fluphenazine—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00418	CcSEcCtD
Fluphenazine—HTR2A—trachea—chronic obstructive pulmonary disease	0.00043	0.0116	CbGeAlD
Fluphenazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.00414	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.00413	CcSEcCtD
Fluphenazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.00408	CcSEcCtD
Fluphenazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000422	0.00408	CcSEcCtD
Fluphenazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00406	CcSEcCtD
Fluphenazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00406	CcSEcCtD
Fluphenazine—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00403	CcSEcCtD
Fluphenazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000413	0.004	CcSEcCtD
Fluphenazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00397	CcSEcCtD
Fluphenazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.00385	CcSEcCtD
Fluphenazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000397	0.00384	CcSEcCtD
Fluphenazine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.00383	CcSEcCtD
Fluphenazine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000396	0.00383	CcSEcCtD
Fluphenazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00383	CcSEcCtD
Fluphenazine—CYP1A2—lung—chronic obstructive pulmonary disease	0.000395	0.0106	CbGeAlD
Fluphenazine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000393	0.0038	CcSEcCtD
Fluphenazine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000391	0.00378	CcSEcCtD
Fluphenazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000389	0.00376	CcSEcCtD
Fluphenazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.0037	CcSEcCtD
Fluphenazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000382	0.0037	CcSEcCtD
Fluphenazine—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000382	0.0103	CbGeAlD
Fluphenazine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000375	0.00362	CcSEcCtD
Fluphenazine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000375	0.00362	CcSEcCtD
Fluphenazine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.00362	CcSEcCtD
Fluphenazine—HRH1—lung—chronic obstructive pulmonary disease	0.00037	0.00996	CbGeAlD
Fluphenazine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000369	0.00357	CcSEcCtD
Fluphenazine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00355	CcSEcCtD
Fluphenazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.00354	CcSEcCtD
Fluphenazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000366	0.00354	CcSEcCtD
Fluphenazine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000364	0.00352	CcSEcCtD
Fluphenazine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000364	0.00352	CcSEcCtD
Fluphenazine—ADRA2A—lung—chronic obstructive pulmonary disease	0.000364	0.00978	CbGeAlD
Fluphenazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000363	0.00351	CcSEcCtD
Fluphenazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00349	CcSEcCtD
Fluphenazine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000357	0.00345	CcSEcCtD
Fluphenazine—CYP2E1—lung—chronic obstructive pulmonary disease	0.000356	0.00957	CbGeAlD
Fluphenazine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00342	CcSEcCtD
Fluphenazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00035	0.00339	CcSEcCtD
Fluphenazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00035	0.00339	CcSEcCtD
Fluphenazine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000348	0.00337	CcSEcCtD
Fluphenazine—Flupentixol—HTR2A—chronic obstructive pulmonary disease	0.000346	0.0672	CrCbGaD
Fluphenazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000345	0.00334	CcSEcCtD
Fluphenazine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000344	0.00332	CcSEcCtD
Fluphenazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.00331	CcSEcCtD
Fluphenazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00323	CcSEcCtD
Fluphenazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00323	CcSEcCtD
Fluphenazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00322	CcSEcCtD
Fluphenazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00322	CcSEcCtD
Fluphenazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.0032	CcSEcCtD
Fluphenazine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000329	0.00318	CcSEcCtD
Fluphenazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00316	CcSEcCtD
Fluphenazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.0031	CcSEcCtD
Fluphenazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000321	0.0031	CcSEcCtD
Fluphenazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000316	0.00305	CcSEcCtD
Fluphenazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00304	CcSEcCtD
Fluphenazine—HTR2A—lung—chronic obstructive pulmonary disease	0.000309	0.00832	CbGeAlD
Fluphenazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000309	0.00298	CcSEcCtD
Fluphenazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00298	CcSEcCtD
Fluphenazine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00296	CcSEcCtD
Fluphenazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.00293	CcSEcCtD
Fluphenazine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000298	0.00288	CcSEcCtD
Fluphenazine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.00288	CcSEcCtD
Fluphenazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000296	0.00287	CcSEcCtD
Fluphenazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000296	0.00287	CcSEcCtD
Fluphenazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000293	0.00283	CcSEcCtD
Fluphenazine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000292	0.00282	CcSEcCtD
Fluphenazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000291	0.00281	CcSEcCtD
Fluphenazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00029	0.00281	CcSEcCtD
Fluphenazine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00276	CcSEcCtD
Fluphenazine—ABCB1—trachea—chronic obstructive pulmonary disease	0.000282	0.00758	CbGeAlD
Fluphenazine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000281	0.00272	CcSEcCtD
Fluphenazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00271	CcSEcCtD
Fluphenazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00267	CcSEcCtD
Fluphenazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00267	CcSEcCtD
Fluphenazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000276	0.00267	CcSEcCtD
Fluphenazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.000271	0.0527	CrCbGaD
Fluphenazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00262	CcSEcCtD
Fluphenazine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00256	CcSEcCtD
Fluphenazine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00256	CcSEcCtD
Fluphenazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00252	CcSEcCtD
Fluphenazine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00251	CcSEcCtD
Fluphenazine—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000252	0.0488	CrCbGaD
Fluphenazine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00242	CcSEcCtD
Fluphenazine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00241	CcSEcCtD
Fluphenazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000235	0.00227	CcSEcCtD
Fluphenazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.00227	CcSEcCtD
Fluphenazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00227	CcSEcCtD
Fluphenazine—Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.000233	0.0452	CrCbGaD
Fluphenazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.00023	0.00222	CcSEcCtD
Fluphenazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000227	0.0022	CcSEcCtD
Fluphenazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00215	CcSEcCtD
Fluphenazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00215	CcSEcCtD
Fluphenazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.00214	CcSEcCtD
Fluphenazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00211	CcSEcCtD
Fluphenazine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000215	0.00208	CcSEcCtD
Fluphenazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00203	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00196	CcSEcCtD
Fluphenazine—ABCB1—lung—chronic obstructive pulmonary disease	0.000203	0.00545	CbGeAlD
Fluphenazine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.0386	CrCbGaD
Fluphenazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.0386	CrCbGaD
Fluphenazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.00192	CcSEcCtD
Fluphenazine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000194	0.0378	CrCbGaD
Fluphenazine—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000193	0.0375	CrCbGaD
Fluphenazine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000181	0.00175	CcSEcCtD
Fluphenazine—Trazodone—HTR2A—chronic obstructive pulmonary disease	0.000179	0.0347	CrCbGaD
Fluphenazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.000174	0.0338	CrCbGaD
Fluphenazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.00017	0.0331	CrCbGaD
Fluphenazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00017	0.00165	CcSEcCtD
Fluphenazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.000168	0.0325	CrCbGaD
Fluphenazine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.000168	0.0325	CrCbGaD
Fluphenazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00161	CcSEcCtD
Fluphenazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.000165	0.0321	CrCbGaD
Fluphenazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000165	0.0016	CcSEcCtD
Fluphenazine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00156	CcSEcCtD
Fluphenazine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00151	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00145	CcSEcCtD
Fluphenazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.000148	0.0287	CrCbGaD
Fluphenazine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00143	CcSEcCtD
Fluphenazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000144	0.00139	CcSEcCtD
Fluphenazine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00139	CcSEcCtD
Fluphenazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.0274	CrCbGaD
Fluphenazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.000139	0.0271	CrCbGaD
Fluphenazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.0266	CrCbGaD
Fluphenazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.0264	CrCbGaD
Fluphenazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00124	CcSEcCtD
Fluphenazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00123	CcSEcCtD
Fluphenazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00122	CcSEcCtD
Fluphenazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000125	0.0242	CrCbGaD
Fluphenazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.0238	CrCbGaD
Fluphenazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.00117	CcSEcCtD
Fluphenazine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000119	0.0232	CrCbGaD
Fluphenazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	0.000119	0.0231	CrCbGaD
Fluphenazine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00113	CcSEcCtD
Fluphenazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000117	0.0226	CrCbGaD
Fluphenazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00113	CcSEcCtD
Fluphenazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000116	0.0225	CrCbGaD
Fluphenazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000115	0.0223	CrCbGaD
Fluphenazine—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000115	0.0223	CrCbGaD
Fluphenazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000115	0.0222	CrCbGaD
Fluphenazine—Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0218	CrCbGaD
Fluphenazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00105	CcSEcCtD
Fluphenazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000108	0.0209	CrCbGaD
Fluphenazine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000104	0.00101	CcSEcCtD
Fluphenazine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000103	0.02	CrCbGaD
Fluphenazine—Headache—Prednisone—chronic obstructive pulmonary disease	9.24e-05	0.000894	CcSEcCtD
Fluphenazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	9.09e-05	0.0176	CrCbGaD
Fluphenazine—Nausea—Prednisone—chronic obstructive pulmonary disease	8.76e-05	0.000847	CcSEcCtD
Fluphenazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	6.22e-05	0.0121	CrCbGaD
Fluphenazine—CALM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1e-05	0.00011	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.84e-06	0.000108	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.84e-06	0.000108	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.82e-06	0.000108	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.79e-06	0.000107	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.79e-06	0.000107	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.71e-06	0.000106	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.66e-06	0.000106	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	0.000106	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.61e-06	0.000105	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.59e-06	0.000105	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.59e-06	0.000105	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.58e-06	0.000105	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.53e-06	0.000104	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.5e-06	0.000104	CbGpPWpGaD
Fluphenazine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.45e-06	0.000104	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.000103	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.43e-06	0.000103	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.41e-06	0.000103	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.38e-06	0.000103	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.37e-06	0.000103	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.35e-06	0.000102	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.28e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.28e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.28e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.27e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.27e-06	0.000102	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NOS2—chronic obstructive pulmonary disease	9.26e-06	0.000101	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	9.18e-06	0.000101	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.17e-06	0.0001	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.16e-06	0.0001	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9e-06	9.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—EGFR—chronic obstructive pulmonary disease	8.98e-06	9.84e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NOS2—chronic obstructive pulmonary disease	8.96e-06	9.82e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NOS2—chronic obstructive pulmonary disease	8.96e-06	9.82e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.86e-06	9.7e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.86e-06	9.7e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.74e-06	9.57e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.71e-06	9.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—EGFR—chronic obstructive pulmonary disease	8.69e-06	9.52e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	8.69e-06	9.52e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.67e-06	9.5e-05	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	8.62e-06	9.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.58e-06	9.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.56e-06	9.38e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.53e-06	9.34e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.52e-06	9.34e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.46e-06	9.26e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.39e-06	9.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—chronic obstructive pulmonary disease	8.37e-06	9.17e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.37e-06	9.17e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.34e-06	9.14e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.34e-06	9.14e-05	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	8.34e-06	9.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	8.34e-06	9.14e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.29e-06	9.08e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.28e-06	9.07e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.28e-06	9.07e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.23e-06	9.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.21e-06	8.99e-05	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—chronic obstructive pulmonary disease	8.1e-06	8.87e-05	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—chronic obstructive pulmonary disease	8.1e-06	8.87e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.98e-06	8.74e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.94e-06	8.7e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.88e-06	8.63e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.86e-06	8.61e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.83e-06	8.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—SERPINE1—chronic obstructive pulmonary disease	7.8e-06	8.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.78e-06	8.52e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.76e-06	8.5e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.67e-06	8.4e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.63e-06	8.36e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.62e-06	8.34e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.58e-06	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.58e-06	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.58e-06	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—SERPINE1—chronic obstructive pulmonary disease	7.55e-06	8.27e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.55e-06	8.27e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.53e-06	8.24e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.53e-06	8.24e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.5e-06	8.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.49e-06	8.2e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NOS3—chronic obstructive pulmonary disease	7.45e-06	8.16e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.4e-06	8.11e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.27e-06	7.97e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.27e-06	7.96e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.24e-06	7.94e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.24e-06	7.94e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.23e-06	7.93e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.23e-06	7.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NOS3—chronic obstructive pulmonary disease	7.2e-06	7.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NOS3—chronic obstructive pulmonary disease	7.2e-06	7.89e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	7.15e-06	7.83e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.13e-06	7.81e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.08e-06	7.75e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.04e-06	7.71e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.01e-06	7.68e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.96e-06	7.63e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.9e-06	7.56e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.9e-06	7.55e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.88e-06	7.54e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL1B—chronic obstructive pulmonary disease	6.86e-06	7.52e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.85e-06	7.5e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	6.84e-06	7.49e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.78e-06	7.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.73e-06	7.38e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.73e-06	7.38e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.69e-06	7.33e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.69e-06	7.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.68e-06	7.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—chronic obstructive pulmonary disease	6.68e-06	7.31e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.66e-06	7.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL1B—chronic obstructive pulmonary disease	6.64e-06	7.27e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL1B—chronic obstructive pulmonary disease	6.64e-06	7.27e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.58e-06	7.21e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.57e-06	7.2e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.57e-06	7.19e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.56e-06	7.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ALB—chronic obstructive pulmonary disease	6.52e-06	7.14e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.5e-06	7.12e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.45e-06	7.07e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.42e-06	7.03e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.38e-06	6.99e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.37e-06	6.98e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ALB—chronic obstructive pulmonary disease	6.31e-06	6.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ALB—chronic obstructive pulmonary disease	6.31e-06	6.91e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.28e-06	6.88e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.28e-06	6.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.27e-06	6.87e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.27e-06	6.87e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—NOS3—chronic obstructive pulmonary disease	6.24e-06	6.83e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.13e-06	6.72e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.12e-06	6.71e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.1e-06	6.69e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.09e-06	6.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.03e-06	6.61e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.03e-06	6.61e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.01e-06	6.59e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.99e-06	6.56e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.83e-06	6.39e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.8e-06	6.36e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.8e-06	6.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.72e-06	6.27e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.72e-06	6.26e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.66e-06	6.2e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.59e-06	6.13e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.57e-06	6.1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.56e-06	6.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.54e-06	6.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.54e-06	6.07e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.52e-06	6.04e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.48e-06	6.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.46e-06	5.98e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.41e-06	5.93e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.39e-06	5.9e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.35e-06	5.86e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.3e-06	5.81e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.29e-06	5.79e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.28e-06	5.79e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.28e-06	5.79e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.24e-06	5.74e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—EGFR—chronic obstructive pulmonary disease	5.23e-06	5.73e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.22e-06	5.71e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.21e-06	5.71e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.12e-06	5.61e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.07e-06	5.55e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—EGFR—chronic obstructive pulmonary disease	5.06e-06	5.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—EGFR—chronic obstructive pulmonary disease	5.06e-06	5.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.04e-06	5.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.04e-06	5.53e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.04e-06	5.52e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.03e-06	5.51e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.94e-06	5.41e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—chronic obstructive pulmonary disease	4.92e-06	5.39e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.9e-06	5.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—EGFR—chronic obstructive pulmonary disease	4.83e-06	5.29e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.82e-06	5.28e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.81e-06	5.27e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.78e-06	5.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—chronic obstructive pulmonary disease	4.76e-06	5.22e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—chronic obstructive pulmonary disease	4.76e-06	5.22e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-06	5.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.71e-06	5.17e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.69e-06	5.14e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—EGFR—chronic obstructive pulmonary disease	4.67e-06	5.12e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—EGFR—chronic obstructive pulmonary disease	4.67e-06	5.12e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.66e-06	5.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.63e-06	5.07e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.6e-06	5.04e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.6e-06	5.04e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.59e-06	5.02e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.54e-06	4.98e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.53e-06	4.96e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.52e-06	4.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.47e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.47e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.45e-06	4.88e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.4e-06	4.82e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.26e-06	4.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.26e-06	4.66e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.22e-06	4.63e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.21e-06	4.62e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.18e-06	4.58e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.16e-06	4.55e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.15e-06	4.55e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.15e-06	4.54e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.14e-06	4.53e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.12e-06	4.51e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.07e-06	4.46e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.06e-06	4.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.05e-06	4.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.05e-06	4.43e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—chronic obstructive pulmonary disease	4.02e-06	4.4e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.96e-06	4.34e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	3.94e-06	4.32e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.94e-06	4.31e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—chronic obstructive pulmonary disease	3.89e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—chronic obstructive pulmonary disease	3.89e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.78e-06	4.14e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	4.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.76e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—chronic obstructive pulmonary disease	3.71e-06	4.07e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.71e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.63e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.63e-06	3.98e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.62e-06	3.97e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.6e-06	3.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—chronic obstructive pulmonary disease	3.59e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—chronic obstructive pulmonary disease	3.59e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.48e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.45e-06	3.78e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.42e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.41e-06	3.74e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.38e-06	3.7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.34e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.34e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.27e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.27e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.18e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.13e-06	3.43e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.12e-06	3.42e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.11e-06	3.41e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.85e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.84e-06	3.11e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.75e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.75e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.6e-06	2.85e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.51e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.51e-06	2.75e-05	CbGpPWpGaD
